168 related articles for article (PubMed ID: 17873124)
1. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
2. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT).
Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M
J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741
[TBL] [Abstract][Full Text] [Related]
3. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative analysis of cerebral [
Cruz-Cortes Á; Avendaño-Estrada A; Alcauter S; Núñez-Enríquez JC; Rivera-Bravo B; Olarte-Casas MÁ; Ávila-Rodríguez MÁ
Pediatr Radiol; 2023 Dec; 53(13):2574-2585. PubMed ID: 37910188
[TBL] [Abstract][Full Text] [Related]
5. PET/MRI of metabolic activity in osteoarthritis: A feasibility study.
Kogan F; Fan AP; McWalter EJ; Oei EHG; Quon A; Gold GE
J Magn Reson Imaging; 2017 Jun; 45(6):1736-1745. PubMed ID: 27796082
[TBL] [Abstract][Full Text] [Related]
6. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease.
Cheng VY; Slomka PJ; Le Meunier L; Tamarappoo BK; Nakazato R; Dey D; Berman DS
J Nucl Med; 2012 Apr; 53(4):575-83. PubMed ID: 22419753
[TBL] [Abstract][Full Text] [Related]
7. Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates.
Goutal S; Tournier N; Guillermier M; Van Camp N; Barret O; Gaudin M; Bottlaender M; Hantraye P; Lavisse S
PLoS One; 2020; 15(10):e0240228. PubMed ID: 33017429
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of myocardial viability: meta-analysis and systematic review.
Adhaduk M; Paudel B; Liu K; Ashwath M; Gebska MA; Delcour K; Samuelson RJ; Giudici M
J Nucl Cardiol; 2023 Dec; 30(6):2514-2524. PubMed ID: 37758962
[TBL] [Abstract][Full Text] [Related]
9. Quantitative outcome of registration methods for correcting cardiac drift in cardiac PET/CT imaging.
Nye JA; Tudorascu D; Esteves F; Votaw JR
J Appl Clin Med Phys; 2016 Mar; 17(2):542-549. PubMed ID: 27074462
[TBL] [Abstract][Full Text] [Related]
10. Physiological myocardial
Norikane T; Yamamoto Y; Takami Y; Mitamura K; Kobata T; Maeda Y; Noma T; Nishiyama Y
Asia Ocean J Nucl Med Biol; 2024; 12(1):1-10. PubMed ID: 38164236
[TBL] [Abstract][Full Text] [Related]
11. High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.
Wang Y; Abdelhafez YG; Spencer BA; Verma R; Parikh M; Stollenwerk N; Nardo L; Jones T; Badawi RD; Cherry SR; Wang G
J Nucl Med; 2024 May; 65(5):714-721. PubMed ID: 38548347
[TBL] [Abstract][Full Text] [Related]
12. Validation of automated whole-body analysis of metabolic and morphological parameters from an integrated FDG-PET/MRI acquisition.
Guglielmo P; Ekström S; Strand R; Visvanathar R; Malmberg F; Johansson E; Pereira MJ; Skrtic S; Carlsson BCL; Eriksson JW; Ahlström H; Kullberg J
Sci Rep; 2020 Mar; 10(1):5331. PubMed ID: 32210327
[TBL] [Abstract][Full Text] [Related]
13. A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET.
Nikulin P; Hofheinz F; Maus J; Li Y; Bütof R; Lange C; Furth C; Zschaeck S; Kreissl MC; Kotzerke J; van den Hoff J
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):995-1004. PubMed ID: 33006022
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT.
Chan SH; Huang CK; Luzhbin D; Hou PN; Chang YT; Wu J
J Nucl Cardiol; 2023 Dec; 30(6):2454-2463. PubMed ID: 37258954
[TBL] [Abstract][Full Text] [Related]
15. Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging.
Sanaat A; Shiri I; Arabi H; Mainta I; Nkoulou R; Zaidi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2405-2415. PubMed ID: 33495927
[TBL] [Abstract][Full Text] [Related]
16. STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis.
Ye Z; Lu X; Zhu M; Bi L; Yang F; Zhou B; Xu D; Yao L
Mol Pharm; 2024 Jun; 21(6):2865-2877. PubMed ID: 38666508
[TBL] [Abstract][Full Text] [Related]
17. Myocardial Infarction and Cardiac Arrest During Acquisition of 18 F-FDG PET/CT.
Omery BM; Kalirao AS
Clin Nucl Med; 2024 Jun; 49(6):580-581. PubMed ID: 38389214
[TBL] [Abstract][Full Text] [Related]
18. A feasibility study of [18F]F-AraG positron emission tomography (PET) for cardiac imaging - myocardial viability in ischemia-reperfusion injury model.
Shrestha U; Chae HD; Fang Q; Lee RJ; Packiasamy J; Huynh L; Blecha J; Huynh TL; VanBrocklin HF; Levi J; Seo Y
Res Sq; 2024 Apr; ():. PubMed ID: 38746162
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
